Back
Coca-Cola Femsa SAB de CV Vs. Viking Therapeutics Industry Stock Comparison
Sell
49
KOF
Coca-Cola Femsa SAB de CV
Last Price:
85.74
Seasonality Move:
0.17%
Sell
47
VKTX
Viking Therapeutics
Last Price:
54.13
Seasonality Move:
8.99%
Sell
49
Coca-Cola Femsa SAB de CV (KOF)
is a Sell
Is Coca-Cola Femsa SAB de CV a Buy, Sell or Hold?
- The current Coca-Cola Femsa SAB de CV [KOF] share price is $85.83. The Score for KOF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- KOF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $54.16. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KOF Stock Price Chart
What is Coca-Cola Femsa SAB de CV's stock price today?
-
The Coca-Cola Femsa SAB de CV share price today is $85.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KOF is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $54.16
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
KOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.47 | Sell |
Relative Strength Index (14 RSI): | 45.42 | Sell |
Chaikin Money Flow: | -58873 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (85.7 - 89.06) | Sell |
Bollinger Bands (100): | (84.82 - 95.64) | Sell |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 40.93 | Sell |
Chaikin Money Flow: | 868119 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.37 - 63.73) | Sell |
Bollinger Bands (100): | (52.14 - 69.1) | Sell |
KOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.03 | Sell |
20-day SMA: | 87.7 | Sell |
50-day SMA: | 86.84 | Sell |
200-day SMA: | 92.22 | Sell |
8-day EMA: | 86.37 | Sell |
20-day EMA: | 87.01 | Sell |
50-day EMA: | 87.74 | Sell |
200-day EMA: | 89.13 | Sell |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.42 | Sell |
20-day SMA: | 60.55 | Sell |
50-day SMA: | 56.97 | Sell |
200-day SMA: | 50.23 | Buy |
8-day EMA: | 58.53 | Sell |
20-day EMA: | 59.39 | Sell |
50-day EMA: | 58.62 | Sell |
200-day EMA: | 50.21 | Buy |
Coca-Cola Femsa SAB de CV Earnings Growth & KOF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.12 per share, an increase this year of $0.17 per share, and an increase next year of $1.05 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.59 per share.
Coca-Cola Femsa SAB de CV Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |